Very long-term prognosis in patients with right ventricular apical pacing for sick sinus syndrome.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
10 2019
Historique:
received: 26 11 2018
revised: 26 03 2019
accepted: 01 04 2019
pubmed: 26 4 2019
medline: 9 6 2020
entrez: 26 4 2019
Statut: ppublish

Résumé

The impact of right ventricular (RV) apical pacing on very long-term cardiac prognosis is little known. In this study, we retrospectively evaluated the relationship between RV apical pacing and cardiovascular events (CEs) in patients with sick sinus syndrome (SSS) and left ventricular ejection fraction (LVEF) >35%. Total of 532 consecutive pacemaker recipients with SSS and LVEF >35% were divided into two groups according to the mean cumulative per cent RV apical ventricular pacing (mean %VP) (<50%; non-VP group vs ≥50%; VP group) and occurrence of CE was compared using Kaplan-Meier analysis between two groups. Cox hazard model was used to assess predictors of CE after adjusting explanatory variables such as age, atrial fibrillation (AF) and structural heart disease (SHD). Mean %VP was 86.0% and 8.2% in VP and non-VP groups, respectively (p<0.001). During mean follow-up of 13.4±7.0 years, CE occurred in 131 patients and more frequently in VP than non-VP group (p<0.001). However, the VP group was no longer associated with CE after taking into account other variables in multivariate analysis, which revealed AF (HR (HR)=2.08), SHD (HR=4.97), low LVEF (HR=0.98 for every 1% increase) and high age (HR=1.03 for every year of age) were independent predictors for CE. Regarding patients with SHD and/or AF and those aged ≥75 years, Kaplan-Meier curves showed both groups had similar prognosis. Cardiac prognosis of patients with RV apical pacing was poor, but after adjusting for other predictors of CE, RV apical pacing was not a prognostic factor in patients with SSS with LVEF >35%.

Identifiants

pubmed: 31018954
pii: heartjnl-2018-314537
doi: 10.1136/heartjnl-2018-314537
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1493-1499

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kosuke Nakasuka (K)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.
Department of Cardiorenal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Kohei Ishibashi (K)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Ayako Kamijima (A)

Department of Cardiology, Iida Municipal Hospital, Iida, Nagano, Japan.

Tsukasa Kamakura (T)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Mitsuru Wada (M)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Yuko Inoue (Y)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Koji Miyamoto (K)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Hideo Okamura (H)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Satoshi Nagase (S)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Takashi Noda (T)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Takeshi Aiba (T)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Nobuyuki Ohte (N)

Department of Cardiorenal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Kengo Kusano (K)

Department of Cardiovascular Medicine, Natonal Cerebral and Cardiovascular Center, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH